13F-HR/A filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2020-09-30, filed 2023-11-08, with 48 holding rows worth $449,433,731.
- Accession
- 0001697013-23-000017
- Filer
- CIK 1697013
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, amendment of type restatement, 48 entries on the cover page, a total value of $449,433,731 stated on the cover page (in dollars after the unit check, H1), rows summing to $449,433,731 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 607,757 | $47,210,564 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 10,653,459 | $44,851,062 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,023,330 | $27,384,311 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 161,004 | $24,846,137 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 240,904 | $24,331,304 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,394,355 | $21,573,139 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 535,036 | $21,385,389 | dollars as filed | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 321,581 | $20,905,981 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 402,433 | $20,644,813 | dollars as filed | |
| ENSIGN GROUP INC | 29358P101 | COM | 318,863 | $18,210,266 | dollars as filed | |
| HESKA CORP | 42805E306 | COM | 158,772 | $15,685,086 | dollars as filed | |
| ZOGENIX INC. | 98978L204 | Common Stock | 865,241 | $15,513,771 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 140,329 | $12,020,582 | dollars as filed | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 940,412 | $11,444,814 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 2,656,208 | $10,306,087 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 1,302,353 | $9,676,483 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 167,473 | $8,752,139 | dollars as filed | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 141,889 | $7,782,612 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 31,360 | $6,757,938 | dollars as filed | |
| MODEL N INC | 607525102 | COM | 188,967 | $6,666,756 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 52,400 | $6,533,232 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 435,995 | $6,422,206 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,264,100 | $5,321,861 | dollars as filed | call |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 98,501 | $5,169,332 | dollars as filed | |
| MYLAN NV | N59465109 | SHS EURO | 324,951 | $4,819,023 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 176,758 | $4,535,610 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 1,245,458 | $4,222,103 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,143,211 | $3,926,930 | dollars as filed | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 293,277 | $3,431,341 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,936 | $3,339,293 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 140,000 | $2,606,800 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 49,778 | $2,497,362 | dollars as filed | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 64,372 | $2,453,292 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 81,267 | $2,451,825 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 150,494 | $2,231,826 | dollars as filed | |
| SESEN BIO INC | 817763105 | COM | 1,559,824 | $2,183,754 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 9,343 | $2,049,667 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 197,028 | $1,968,310 | dollars as filed | |
| OTONOMY INC | 68906L105 | COM | 412,500 | $1,670,625 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 107,300 | $1,350,907 | dollars as filed | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 103,829 | $1,019,601 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 182,751 | $899,135 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 307,024 | $623,259 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 36,310 | $611,097 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 65,605 | $488,757 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,897 | $266,396 | dollars as filed | |
| TELIGENT INC NEW COM NEW | 87960W203 | COM | 305,423 | $219,935 | dollars as filed | |
| GOHEALTH INC | 38046W105 | COM CL A | 13,130 | $171,018 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-20-000007 | superseded | 2020-11-12 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-20-000008 | superseded | 2020-11-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000017 | this filing | 2023-11-08 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000018 | added | 2023-11-08 | acceptance time not in the bulk data set |